As shown in Figures 4A–D, the percentages of IELs CD3+, CD3+CD4+, and CD3+CD8+ in the MD group decreased significantly at 28 (p < 0.05) and 42 days of age (p < 0.01) compared to the control group. This evidence concerns the gene CD8A and Menkes disease.